Larmor Bio, Inc. is a life sciences and clinical diagnostics company developing the BioScan-NMR™ platform, a next-generation microscale nuclear magnetic resonance (NMR) system for rapid, label-free phenotyping of live cells and micro-sized biological samples. Founded as a Massachusetts Institute of Technology (MIT) spin-off, Larmor Bio’s technology is designed to deliver molecular-level diagnostic information from small sample volumes in minutes, without the cryogenics, dedicated infrastructure, or specialized personnel required by conventional NMR instrumentation. The Company’s platform supports applications across bioprocessing, cell and gene therapy development, and clinical diagnostics. For more information, visit www.larmorbio.com.
| Website | https://www.larmorbio.com |
| Employees | 8 (3 on RocketReach) |
| Founded | 2022 |
| Phone | +1 212-674-3456 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, High Resolution Imaging, Drug Discovery, Biomarker Discovery, Diagnostic Tools, Therapeutics Development, Precision Medicine, Life Sciences, Biomedical Research, Molecular Imaging, Microscopy, Biosensors, Proteomics, Genomics, Translational Research, Biomarker Validation, Clinical Diagnostics, Pharmaceutical Research |
Looking for a particular LarmorBio employee's phone or email?
LarmorBio Questions
Rodolfo Rohr is the CEO of LarmorBio.
3 people are employed at LarmorBio.
Top LarmorBio Employees
-
Rodolfo Rohr
Chief Executive Officer at LarmorBio
Boston, MA, US33 -
Michael McPhaul
Chief Medical Officer at LarmorBio
San Juan Capistrano, CA, US2
